Can you provide the last earnings date for AGILE THERAPEUTICS INC?
AGILE THERAPEUTICS INC (AGRX) last reported earnings on 3/28/2024.
AGILE THERAPEUTICS INC (AGRX) Earnings History & Surprises
NASDAQ:AGRX • US00847L3087
Current stock price
0.6022 USD
+0.06 (+10.11%)
At close:
0.2408 USD
-0.36 (-60.01%)
After Hours:
AGRX Earnings overview
Past quarterly earnings results for AGILE THERAPEUTICS INC (AGRX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 9, 2024
- Period
- Q1 / 2024
- EPS Estimate
- -$0.52
- Revenue Estimate
- 3.827M
Last Reported
Most Recent- Release Date
- Mar 28, 2024
- Period
- Q4 / 2023
- EPS Reported
- -$1.51
- EPS Surprise
- -60.91%
- Revenue Surprise
- %
Beat Rate
Last 8 Quarters 75%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2023 | -1.51 | -0.94 | -60.91% | 69.80% | 4.15M | - | 3.75% | |
| Q3 2023 | -0.27 | -1.88 | 85.61% | 98.98% | 6.66M | 6.904M | -3.53% | 122.00% |
| Q2 2023 | -2.15 | -7.14 | 69.89% | 98.41% | 5.5M | 4.158M | 32.28% | 158.22% |
| Q1 2023 | -5.91 | -7.65 | 22.75% | -56.35% | 3.81M | 3.465M | 9.96% | 116.48% |
| Q4 2022 | -5.00 | -11.73 | 57.37% | 98.75% | 4M | 3.147M | 27.11% | 164.90% |
| Q3 2022 | -26.50 | -22.44 | -18.09% | -268.06% | 3M | 2.38M | 26.05% | 132.56% |
| Q2 2022 | -135.50 | -188.70 | 28.19% | -1,593.75% | 2.13M | 2.021M | 5.39% | 78.99% |
| Q1 2022 | -3.78 | -4.90 | 22.79% | 52.75% | 1.76M | 1.491M | 18.04% | 1,366.67% |
| Q4 2021 | -400.00 | -306.00 | -30.72% | -4,900.00% | 1.51M | 1.542M | -2.08% | 101.33% |
| Q3 2021 | -7.20 | -7.85 | 8.33% | - | 1.29M | 1.491M | -13.48% | - |
| Q2 2021 | -8.00 | -8.81 | 9.22% | -66.67% | 1.19M | 1.156M | 2.94% | - |
| Q1 2021 | -8.00 | -8.73 | 8.37% | -100.00% | 120K | 264.384K | -54.61% | - |
| Q4 2020 | -8.00 | -9.14 | 12.46% | - | 750K | 1.027M | -26.97% | - |
| Q3 2020 | -7.20 | -7.26 | 0.86% | - | - | - | ||
| Q2 2020 | -4.80 | -5.71 | 15.97% | - | - | - | ||
| Q1 2020 | -4.00 | -3.59 | -11.41% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
58.91%
Max EPS beat (4)
85.61%
Min EPS beat (4)
22.75%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
16.45%
Max Revenue beat (4)
32.28%
Min Revenue beat (4)
-3.53%
Analysis
In the last 4 quarters, AGRX has consistently beaten EPS estimates in all releases
AGRX has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, AGRX has beaten the EPS estimates by 58.9% on average.
In the last 4 quarters, AGRX has beaten the revenue estimates by 16.5% on average.
Related analysis
AGILE THERAPEUTICS INC / AGRX Earnings FAQ
Can you provide information on whether AGILE THERAPEUTICS INC beat earnings estimates in the last quarter?
AGILE THERAPEUTICS INC (AGRX) missed EPS estimates and missed revenue estimates in the most recent quarter.
How often does AGILE THERAPEUTICS INC (AGRX) beat earnings estimates?
In the last 4 quarters, AGILE THERAPEUTICS INC (AGRX) has beaten EPS estimates in 4 out of 4 releases.